Coherus Oncology (CHRS) Current Leases (2025 - 2026)

Coherus Oncology has disclosed Current Leases across 2 years of filings, most recently posting $1.9 million for Q2 2026.

• In Q2 2026, Current Leases changed N/A year-over-year to $1.9 million; the TTM figure through Jun 2026 stood at $1.9 million (changed N/A YoY), while the FY2025 annual figure was $1.8 million, changed N/A from the prior year.
• Current Leases came in at $1.9 million for Q2 2026 at Coherus Oncology, up from $1.8 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $1.9 million in Q2 2026 to a low of $1.8 million in Q4 2025.